Press Release
Health

New Technology Developments in Natural Killer Cells Therapeutics Market to Grow during Forecast 2018–2026

A Comprehensive research study conducted by KD Market Insights on ” Natural Killer Cells Therapeutics Market – By Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026 ” report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Natural Killer Cells Therapeutics Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

Natural killer (NK) cell is a component of innate immunity system that targets cancer cells and can be used as a therapeutic agent. NK cells target the cells losing MHC-I in cancer, a phenotype that is similar to certain cells in immune-privileged sites whose milieus are separated from peripheral blood. The global natural killer cell therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026.

Request for Sample @ https://www.kdmarketinsights.com/sample/5441 
 
The growth of the global natural killer cell therapeutics market is driven by rise in use of NK cells to treat cancer, infections, and liver diseases. Moreover, NK cells play vital role in tumor immune surveillance, which has significantly boosted their adoption across the globe. In addition, rise in awareness among the population regarding various immunotherapies and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the global natural killer cell therapeutics market growth. However, lack of specificity and poor in-vivo survival of the cells limit the growth of the market. Furthermore, higher costs associated with the therapies and adverse side effects are expected to hamper the market growth in the coming years. Conversely, significant surge in R&D activities toward development of immunotherapy in developing economies is anticipated to offer lucrative opportunities for the market.

The global natural killer cell therapeutics market is segmented based on therapeutics, application, end user, and region. Depending on therapeutics, the natural killer cells therapeutics market is classified into NK cell therapies and NK cell directed antibodies. By application, it is categorized into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. On the basis of end user, it is segregated into hospitals, research centers & institutes, and others. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
– This report entails a detailed quantitative analysis along with the current market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
– The global natural killer cell therapeutics market size and estimations are based on a comprehensive analysis of key developments.
– A qualitative analysis based on innovative products facilitates strategic business planning.
– The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key Market Segments
By Therapeutics
– NK Cell Therapies
– NK Cell Directed Antibodies

By Application
– Cancer
– Gastrointestinal Diseases
– Immunoproliferative Disorders
– Others

By End User
– Research Centers & Institutes
– Hospitals
– Others

By Region
North America
– U.S.
– Canada
– Mexico
Europe
– Germany
– France
– UK
– Italy
– Spain
– Rest of Europe
Asia-Pacific
– Japan
– China
– India
– Australia
– Rest of Asia-Pacific
LAMEA
– Brazil
– Saudi Arabia
– South Africa
– Rest of LAMEA

The key players profiled in this report are as follows:
– Affimed N.V.
– Celgene Corporation
– Fate Therapeutics
– Fortress Biotech
– Glycostem Therapeutics BV
– Innate Pharma S.A.
– Nantkwest Inc.
– Nkarta Therapeutics, Inc.
– NKT Therapeutics Inc.
– Ziopharm Oncology Inc.

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/natural-killer-cells-therapeutics-market-amr

Table of Contents:
 
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in incidence of cancer across the globe
3.5.1.2. Increase in government expenditure on healthcare
3.5.1.3. Surge in awareness regarding immunotherapy
3.5.2. Restraints
3.5.2.1. High cost of cancer immunotherapy treatment
3.5.2.2. Stringent government regulations toward approval of immunotherapy
3.5.3. Opportunity
3.5.3.1. Surge in R&D activities toward the development of immunotherapy
3.6. Government regulatory scenerio
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.6.4. Thailand
3.6.5. Singapore
3.6.6. Malaysia
3.6.7. Mexico
3.6.8. Australia

CHAPTER 4: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY THERAPEUTICS
4.1. Overview
4.1.1. Market and forecast
4.2. Natural killer cell therapies
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.3.1. CNDO-109
4.2.3.2. oNKord
4.2.3.3. Natural Killer Cells
4.2.3.4. Others
4.3. NK cell-directed antibodies
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.3.1. MOGAMULIZUMAB
4.3.3.2. Lirilumab
4.3.3.3. AFM13
4.3.3.4. NKTT 120
4.3.3.5. Others
CHAPTER 5: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Cancer
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Gastrointestinal diseases
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Immunoproliferative disorders
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country

CHAPTER 6: NATURAL KILLER CELLS THERAPEUTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market and forecast
6.2. Research centers and institutes
6.2.1. Market and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals and clinics
6.3.1. Market and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: NATURAL KILLER CELL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by therapeutics
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by therapeutics
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by end user
7.2.5.4. Canada market size and forecast, by therapeutics
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by end user
7.2.5.7. Mexico market size and forecast, by therapeutics
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by therapeutics
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. UK market size and forecast, by therapeutics
7.3.5.2. UK market size and forecast, by application
7.3.5.3. UK market size and forecast, by end user
7.3.5.4. Germany market size and forecast, by therapeutics
7.3.5.5. Germany market size and forecast, by application
7.3.5.6. Germany market size and forecast, by end user
7.3.5.7. France market size and forecast, by therapeutics
7.3.5.8. France market size and forecast, by application
7.3.5.9. France market size and forecast, by end user
7.3.5.10. Italy market size and forecast, by therapeutics
7.3.5.11. Italy market size and forecast, by application
7.3.5.12. Italy market size and forecast, by end user
7.3.5.13. Spain market size and forecast, by therapeutics
7.3.5.14. Spain market size and forecast, by application
7.3.5.15. Spain market size and forecast, by end user
7.3.5.16. Rest of Europe market size and forecast, by therapeutics
7.3.5.17. Rest of Europe market size and forecast, by application
7.3.5.18. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by therapeutics
7.4.3. Market size and forecast, by application
7.4.4. Market size and forecast, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan market size and forecast, by therapeutics
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by end user
7.4.5.4. China market size and forecast, by therapeutics
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by end user
7.4.5.7. Australia market size and forecast, by therapeutics
7.4.5.8. Australia market size and forecast, by application
7.4.5.9. Australia market size and forecast, by end user
7.4.5.10. India market size and forecast, by therapeutics
7.4.5.11. India market size and forecast, by application
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Rest of Asia-Pacific market size and forecast, by therapeutics
7.4.5.14. Rest of Asia-Pacific market size and forecast, by application
7.4.5.15. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by therapeutics
7.5.3. Market size and forecast, by application
7.5.4. Market size and forecast, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by therapeutics
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by end user
7.5.5.4. Saudi Arabia market size and forecast, by therapeutics
7.5.5.5. Saudi Arabia market size and forecast, by application
7.5.5.6. Saudi Arabia market size and forecast, by end user
7.5.5.7. South Africa market size and forecast, by therapeutics
7.5.5.8. South Africa market size and forecast, by application
7.5.5.9. South Africa market size and forecast, by end user
7.5.5.10. Rest of LAMEA market size and forecast, by therapeutics
7.5.5.11. Rest of LAMEA market size and forecast, by application
7.5.5.12. Rest of LAMEA market size and forecast, by end user
Continue….
 
Check for Discount @ https://www.kdmarketinsights.com/discount/5441 

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:
 
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.kdmarketinsights.com
Read More News: https://marketreserachtab.blogspot.com/
https://kdmarketinsights.blogspot.com